Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Antiaging Quantum Living (AAQL) EBT (2020 - 2025)

Historic EBT for Antiaging Quantum Living (AAQL) over the last 6 years, with Q4 2025 value amounting to -$272113.0.

  • Antiaging Quantum Living's EBT fell 11068.88% to -$272113.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$630239.0, marking a year-over-year increase of 2147.37%. This contributed to the annual value of -$720409.0 for FY2025, which is 7444.54% down from last year.
  • Latest data reveals that Antiaging Quantum Living reported EBT of -$272113.0 as of Q4 2025, which was down 11068.88% from -$51153.0 recorded in Q3 2025.
  • In the past 5 years, Antiaging Quantum Living's EBT registered a high of -$1520.0 during Q3 2022, and its lowest value of -$272113.0 during Q4 2025.
  • In the last 5 years, Antiaging Quantum Living's EBT had a median value of -$29727.0 in 2023 and averaged -$87750.7.
  • As far as peak fluctuations go, Antiaging Quantum Living's EBT surged by 7806.95% in 2022, and later tumbled by 351917.6% in 2024.
  • Antiaging Quantum Living's EBT (Quarter) stood at -$19310.0 in 2021, then soared by 64.93% to -$6772.0 in 2022, then plummeted by 1333.7% to -$97090.0 in 2023, then crashed by 33.03% to -$129154.0 in 2024, then plummeted by 110.69% to -$272113.0 in 2025.
  • Its EBT stands at -$272113.0 for Q4 2025, versus -$51153.0 for Q3 2025 and -$127372.0 for Q2 2025.